yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38922215-2B61323C-F53D-4580-9899-C6C602EB74DD
Q38922215-2B61323C-F53D-4580-9899-C6C602EB74DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38922215-2B61323C-F53D-4580-9899-C6C602EB74DD
Multi-synergetic ZnO platform for high performance cancer therapy.
P2860
Q38922215-2B61323C-F53D-4580-9899-C6C602EB74DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38922215-2B61323C-F53D-4580-9899-C6C602EB74DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d452acedf6357867f27bf591ca48fcf9bc33d115
P2860
A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.